Veterinary Medicines

Rispoval IBR-Marker Vivum, Lyophilisate and diluent for suspension for injection for cattle

Authorised
  • Bovine herpesvirus 1, strain Difivac gE gene-deleted, Live
Download as PDF

Product identification

Medicine name:
Rispoval IBR-Marker Live
Rispoval IBR-Marker Vivum, Lyophilisate and diluent for suspension for injection for cattle
Active substance:
  • Bovine herpesvirus 1, strain Difivac gE gene-deleted, Live
Target species:
  • Cattle
  • Cattle (for meat production)
  • Cattle (calf)
  • Cattle (heifer)
  • Cattle (suckling calf)
Route of administration:
  • Nasal use
  • Nasal use

Product details

Active substance and strength:
  • Bovine herpesvirus 1, strain Difivac gE gene-deleted, Live
    10000000.00
    50% cell culture infectious dose
    /
    1.00
    Dose
Pharmaceutical form:
  • Lyophilisate and solvent for suspension for injection
Withdrawal period by route of administration:
  • Nasal use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cattle (for meat production)
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Cattle (heifer)
      • Meat and offal
        0
        day
    • Cattle (suckling calf)
      • Meat and offal
        0
        day
  • Nasal use
    • Cattle
      • Milk
        0
        day
      • Meat and offal
        0
        day
    • Cattle (for meat production)
      • Meat and offal
        0
        day
    • Cattle (calf)
      • Meat and offal
        0
        day
    • Cattle (heifer)
      • Meat and offal
        0
        day
    • Cattle (suckling calf)
      • Meat and offal
        0
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02AD01
Legal status of supply:
  • Veterinary medicinal product not subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Ireland
Available in:
  • Ireland
Package description:
  • (ID2) 50 Dose; 100 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 50 Dose and 1 Bottle (Glass) with 100 millilitre(s)
  • (ID1) 10 Dose; 20 millilitre(s): Box (Cardboard) with 1 Bottle (Glass) with 10 Dose and 1 Bottle (Glass) with 20 millilitre(s)

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Immunological veterinary medicinal product application (Article 13d of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Zoetis Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Zoetis Belgium
Responsible authority:
  • Health Products Regulatory Authority
Authorisation number:
  • VPA10387/062/001
Date of authorisation status change:
Reference member state:
  • Germany
Procedure number:
  • DE/V/0022/001
Concerned member states:
  • Belgium
  • Bulgaria
  • Czechia
  • Estonia
  • Hungary
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Luxembourg
  • Netherlands
  • Poland
  • Portugal
  • Romania
  • Slovakia
  • Slovenia
  • Spain
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 4/07/2024
Download